Abbott
Abbott is a global leader in in-vitro diagnostics with one of the broadest portfolios of businesses spanning every segment – point of care, immunoassay, clinical chemistry, hematology, blood screening, molecular and informatics. Molecular Diagnostics has been releasing oncology FISH and PCR assays since 1999. The team at Molecular Diagnostics brings their expertise, passion, and commitment to creating Companion Diagnostics solutions, with well-established CDx development models which embody emerging technology and innovative solutions to help deliver therapeutic success.
